Effects of piperacillin/tazobactam on Clostridium difficile growth and toxin production in a human gut model

Keyphrases

• Aerobic Bacteria 33%
• Aminopenicillin 33%
• Anaerobic Bacteria 33%
• Antimicrobial 66%
• Clostridioides Difficile 100%
• Clostridium Difficile Infection 100%
• Growth Productions 100%
• Gut Model 100%
• Human Gut 100%
• Lincosamides 33%
• Nosocomial Environment 33%
• Piperacillin-tazobactam 100%
• Spectrum of Activity 33%
• Third-generation Cephalosporins 33%
• Toxin Production 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Aerobic Bacterium 33%
• Aminopenicillin 33%
• Anaerobic Bacterium 33%
• Antiinfective Agent 33%
• Clostridium Difficile Infection 100%
• Lincosamide 33%
• Peptoclostridium difficile 100%
• Piperacillin Plus Tazobactam 100%
• Third Generation Cephalosporin 33%
• Ureidopenicillin 33%

Immunology and Microbiology

• Aerobic Bacterium 25%
• Anaerobic Bacterium 25%
• Peptoclostridium difficile 100%